Saripada, Amina M.

HRN: 23-22-97  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/26/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/26/2026
02/05/2026
IV
600mg
Q8
Dm Foot
Checking Initial Appropriateness 
01/26/2026
CEFTRIAXONE 1G (VIAL)
01/26/2026
02/02/2026
IV
2g
Od
Dm Foot
Checking Initial Appropriateness 
01/26/2026
CEFTRIAXONE 1G (VIAL)
01/26/2026
02/02/2026
IV
2g
Od
Dm Foot
Checking Initial Appropriateness 
01/29/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/29/2026
02/05/2026
IVTT
4.5g
Q6H
CAP
Checking Initial Appropriateness 
02/05/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/05/2026
02/07/2026
IV
1,120LD; Then 840mg
To Run Each Dose For 3 Hours
DM Foot Right; CAP MR
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: